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Abstract
Guttate psoriasis is a less common 
form of psoriasis. It manifests with 
numerous small, teardrop shaped, 
scaly plaques on the trunk and 
extremities. The etiology includes both 
environmental and genetic factors. It 
commonly arises 3-4 weeks following 
a beta hemolytic streptococcal 
infection. In some cases, it may be 
misdiagnosed as an allergy to the 
antibiotics being used to treat the 
streptococcal infection. The treatment 
of guttate psoriasis can vary by 
severity, but the mainstay treatment 
includes photo therapy and topical 
steroids. This case report presents the 
etiology, clinical findings and current 
treatment options of guttate psoriasis. 
It also discusses importance of 
differentiating guttate psoriasis from 
an antibiotic allergy. The confusion 
between the two can often delay and 
make treatment more difficult.
Introduction
Psoriasis is a common skin 
condition affecting 2% of the 
general population. It presents 
as erythematous plaques due 
to the infiltration of inflammatory 
cells and increased proliferation 
of keritinocytes.1 It has multiple 
variants such as plaque, guttate, 
inverse, erythrodermic, and 
pustular. Plaque psoriasis is the 
most common and most chronic. 
Plaque psoriasis presents with 
red, scaly, circular- oval plaques 
located over the extensor surfaces 
and scalp. It is a chronic relapsing 
inflammatory condition with a strong 
familial predisposition.2 Guttate 
psoriasis is a less common form 
of psoriasis, with a prevalence 
of less than 30% of patients with 
psoriasis. It presents with numerous, 
small teardrop shaped plaques 
on the trunk and extremities. 
Guttate psoriasis often follows 
a beta hemolytic streptococcal 
upper respiratory tract infection. 
The plaques usually develop 
3-4 weeks after the infection.3
Post-streptococcal rashes can 
be seen and can be difficult to 
determine the etiology. Common 
rashes seen after beta-hemolytic 
streptococcal infections include 
scarlet fever, drug eruption, and 
guttate psoriasis.4 It is important to 
differentiate between the rashes 
because treatment options as 
well as outcome vary widely. 
Symptoms, clinical findings and 
timing are important characteristics 
to consider when choosing 
from a differential diagnosis.
Case Report
A 53-year-old Caucasian 
female with no history of psoriasis 
presented with sore throat, fever 
and chills for 24 hours. On physical 
exam, she was febrile (101F) and 
in no acute distress. She had 
oropharyngeal erythema, exudate, 
and swollen tonsils. She had normal 
rate and rhythm, normal S1 and 
S2, without murmurs. No swollen 
lymph nodes were appreciated. 
A rapid strep antibody test was 
preformed and was positive for 
beta hemolytic streptococcus. 
She was started on amoxicillin 
875MG oral twice daily for 7 days. 
One week later, she was still 
complaining of sore throat and 
tender lymph nodes on the left 
side of her neck. Per the patient, 
her symptoms only improved to 
90%. On physical exam, she was 
afebrile (98F), had oropharyngeal 
erythema, but no exudate and no 
swollen tonsils. She had anterior 
chain tenderness and enlarged 
anterior chain lymphadenopathy 
on the left side. Since her condition 
improved by 90% on amoxicillin, 
we extended the course of 
antibiotics for 5 more days. 
Five days after finishing the 
antibiotics, she developed a 
rash on her legs that spread to 
her torso within one day. At this 
point, she phoned her primary 
care physician and explained her 
symptoms. It was non-puritic, 
erythematous and raised. At this 
point, “amoxicillin allergy” was added 
to the patient’s medical record 
and she was instructed to come 
in if her symptoms worsened.
The rash persisted for another 3.5 
weeks on the trunk and legs, and 
she returned to her primary care 
physician. Some of the areas began 
to change and look scaly, “like they 
were drying up” but some had new 
erythematous areas, which were 
mildly puritic. On physical exam, 
she had multiple papulosquamous, 
5mm lesions over torso and proximal 
extremities, sparing the hands and 
feet (Figure 1, 2). A diagnosis of 
Guttate Psoriasis was given and 
CBC with diff, CCP and RPR were 
ordered along with a dermatology 
referral. The CBC with diff was within 
normal limits and RPR was negative. 
CCP was within normal limits, 
except for a globulin level of 3.6gm/
dl and a total protein of 8.4gm/dl. 
The dermatologist confirmed the 
diagnosis of guttate psoriasis. 
The patient was treated with 
triamcinolone acetonide Cream 0.1% 
application twice daily for 3 weeks. 
She was also instructed to get as 
much natural sunlight as possible 
without burning. Treament with 
PUVA (psoralen + UVA treatment) 
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was considered, however, at a three-
month follow-up with her primary 
care doctor, her psoriasis was 
resolving, and at one-year follow-
up, it was completely resolved. 
Discussion
Our patient presented with a rash 
2.5 weeks after she was diagnosed 
with strep throat. Initially, the etiology 
of her rash was unclear. Due to the 
frequency of drug-induced allergic 
reactions and failure to visualize the 
rash, she was misdiagnosed with 
an allergy. Amoxicillin is a penicillin 
derivate and one of the most 
common causes of drug-induced 
allergic reaction. Antihistamines 
and systemic corticosteroids are 
recommended for the treatment 
of drug-induced allergic reactions; 
however, many times withdrawal 
of the drug will suffice.5
A drug eruption caused by 
amoxicillin commonly presents 
8-10 days after initiating treatment. 
It manifests as a combination of 
macules and papules and usually 
become confluent affecting large 
areas of the body.5 When the rash 
was visualized 3.5 weeks later, 
it displayed the classic clinical 
findings of guttate psoriasis. The 
rash presented approximately 
2.5 weeks after the diagnosis 
of strep throat and had the 
characteristic distribution to the 
trunk and extremities and the 
classic tear drop appearance.
The etiology of guttate psoriasis 
includes both environmental and 
genetic components. The genetic 
component has been located in the 
MHC region of chromosome 6p21.3 
where the psoriasis susceptibility 
locus (PSORS)1 resides.6 This area 
is thought to house the psoriasis 
gene. HLA-Cw0602, an allele of 
the HLA-C gene has been found 
to have the strongest association 
with psoriasis phenotype. However, 
it is important to note that not all 
HLA-Cw0602 positive individuals 
develop psoriasis and more 
than 30% of psoriasis patients 
are HLA-Cw0602 negative.6 
T cells are thought to play a 
critical role in the pathogenesis 
of guttate psoriasis. Proposed 
mechanisms for the relationship of 
post-streptococcal guttate psoriasis 
have been postulated. Examples 
include cross reactivity between 
streptococcal M proteins presented 
to immune cells in the tonsils and 
structurally similar type I keratins 
in the epidermis trigger a T cell 
mediated autoimmune reaction. 
In addition, recent studies have 
demonstrated that streptococcal M 
proteins and streptococcal pyrogenic 
exotoxins act as superantigens, 
which cause a marked expansion 
of both CD4+, and CD8+ T cells.1 
Evidence of the T cell involvement 
is seen in the effective treatment 
with immunosuppressive drugs 
which inhibit the T cell activation and 
cytokine secretion such as anti-CD3, 
corticosteroids, and cyclosporine A.1
Guttate psoriasis may 
spontaneously remit within 
several weeks to months, it may 
intermittently reoccur, or may persist 
and progress to chronic plaque 
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psoriasis. Due to the potential for 
guttate psoriasis to remit, foregoing 
treatment is an option.7 First 
line therapy includes ultraviolet 
phototherapy. Options include 
narrow band UVB, broadband 
UVB and psoralen plus UVA 
(PUVA). Patients without access to 
phototherapy can see improvement 
in their guttate psoriasis with 
cautious outdoor sun exposure.7 
Topical corticosteroids and 
vitamin D analogues can also be 
used as monotherapy or as an 
adjuvant to phototherapy. Systemic 
immunosuppressive therapies 
utilized for plaque psoriasis may be 
used for guttate psoriasis if first line 
therapy fails.7 Tonsillectomy has 
been documented effective in some 
cases of recurrent post-streptococcal 
associated guttate psoriasis; 
however, data is insufficient to 
recommend routine tonsillectomy. 
Systemic antibiotic therapy 
should be used to treat active 
streptococcal infection; however, 
little evidence shows efficacy in 
using systemic antimicrobials 
for the skin involvement.7 
It is important not to treat 
guttate psoriasis with systemic 
corticosteroids due to the 
rebound flare phenomenon. They 
may temporarily show signs of 
improvement; however, severe 
rebound attacks occur when the 
dose is removed, reduced, or even 
maintained.8 The rebounds tend to 
be worse than the initial eruption, 
and can be life threatening. The 
rebound attack is often unresponsive 
to any form of treatment.8
Conclusion
Guttate psoriasis is important 
for primary care physicians to 
recognize and treat appropriately. 
Due to its common presentation 
after a streptococcal infection and 
probable completion of antibiotic 
therapy, it is important not to confuse 
guttate psoriasis with an antibiotic 
allergy due to the treatment of the 
allergy worsening the psoriasis. 
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Figure 1. Lesions covering patient’s upper back
Figure 2. Closer view of lesions on patient’s upper back
